Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis
By supporting GLP-1 related pathways, the product aims to influence hunger cues, blood sugar handling, and related metabolic processes that are central to healthy weight management
In patients with type 2 DM, GLP-1R agonists have demonstrated a reduction in circumferential strain and improvement in markers of diastolic function, a key component of diabetic cardiomyopathy and the risk of developing heart failure
Almost all patients (95%) were receiving cardiovascular medications (beta blockers, ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers, nitrates, diuretics, aspirin, statins and fibrates)